{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:58:34Z","timestamp":1790852314238,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T00:00:00Z","timestamp":1133827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s10549-005-9118-3","type":"journal-article","created":{"date-parts":[[2005,12,5]],"date-time":"2005-12-05T15:03:14Z","timestamp":1133794994000},"page":"245-254","source":"Crossref","is-referenced-by-count":86,"title":["Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer"],"prefix":"10.1007","volume":"97","author":[{"given":"James J.","family":"Dignam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Wieand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Raich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Somkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Lawrence","family":"Wickerham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,12,6]]},"reference":[{"key":"9118_CR1","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1200\/JCO.2002.20.4.1128","volume":"20","author":"RT Chlebowski","year":"2002","unstructured":"Chlebowski RT, Aiello E, McTiernan A, Weight loss in breast cancer patient managementJ Clin Oncol20:1128\u20131143, 2002","journal-title":"J Clin Oncol"},{"key":"9118_CR2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/oxfordjournals.aje.a115131","volume":"129","author":"R Verreault","year":"1989","unstructured":"Verreault R, Brisson J, Deschenes L, Naud F, Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors Am J Epidemiol 129:260\u2013268, 1989","journal-title":"Am J Epidemiol"},{"key":"9118_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1005798124538","volume":"42","author":"M Jain","year":"1997","unstructured":"Jain M, Miller AB, Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body sizeBreast Cancer Res Treat42:43\u201355, 1997","journal-title":"Breast Cancer Res Treat"},{"key":"9118_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ijc.10209","volume":"98","author":"Y Cui","year":"2002","unstructured":"Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL, Body mass and stage of breast cancer at diagnosisInt J Cancer 98:279\u2013283, 2002","journal-title":"Int J Cancer"},{"key":"9118_CR5","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/jnci\/djg060","volume":"95","author":"JJ Dignam","year":"2003","unstructured":"Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas E, Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early stage breast cancer J Natl Cancer Inst95:1467\u20131476, 2003","journal-title":"J Natl Cancer Inst"},{"key":"9118_CR6","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1023\/B:BREA.0000003693.34935.64","volume":"82","author":"CW Lee","year":"2003","unstructured":"Lee CW, Norris B, Moravan V, Olivotto I, Does body mass index influence the effectiveness of adjuvant tamoxifen in postmenopausal women with early stage breast cancer? Breast Cancer Res Treat82:S71, 2003","journal-title":"Breast Cancer Res Treat"},{"key":"9118_CR7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/annonc\/mdh222","volume":"15","author":"G Berclaz","year":"2004","unstructured":"Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM, Holmberg SB, Lindtner J, Erien D, Collins J, Snyder R, Thurlimann B, Fey MF, Mendiola C, Werner ID, Simoncini E, Crivellari D, Gelber RD, Goldhirsch A, Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group Experience Ann Oncol15:874\u2013884, 2004","journal-title":"Ann Oncol"},{"key":"9118_CR8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01807157","volume":"41","author":"BO Maehle","year":"1996","unstructured":"Maehle BO, Tretli S, Pre-morbid body-mass-index in breast cancer: reversed effect on survival in hormone receptor negative patients Breast Cancer Res Treat41:123\u201330, 1996","journal-title":"Breast Cancer Res Treat"},{"key":"9118_CR9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jnci\/89.5.396","volume":"89","author":"HV Thomas","year":"1997","unstructured":"Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, Wang DY, Re: reversal of relation between body mass and endogenous estrogen concentrations with menopausal status (letter) J Natl Cancer Inst89:396\u2013398, 1997","journal-title":"J Natl Cancer Inst"},{"key":"9118_CR10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/88.11.756","volume":"88","author":"N Potischman","year":"1996","unstructured":"Potischman N, Swanson CA, Siiteri P, Hoover RN, Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status J Natl Cancer Inst88:756\u2013758, 1996","journal-title":"J Natl Cancer Inst"},{"key":"9118_CR11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jnci\/86.9.705","volume":"86","author":"RM Elledge","year":"1994","unstructured":"Elledge RM, Clark GM, Chamness GC, Osborne CK, Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States J Natl Cancer Inst86:705\u2013712, 1994","journal-title":"J Natl Cancer Inst"},{"key":"9118_CR12","first-page":"127","volume":"3","author":"VW Chen","year":"1994","unstructured":"Chen VW, Correa P, Kurman R, Wu XC, Eley JW, Austin D, Muss H, Hunter CP, Redmond C, Sobhan M, Histological characteristics of breast carcinoma in blacks and whites Cancer Epidemiol Biomarkers Prev3:127\u2013135, 1994","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9118_CR13","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2509::AID-CNCR15>3.0.CO;2-V","volume":"83","author":"JG Elmore","year":"1998","unstructured":"Elmore JG, Moceri VM, Carter D, Larson EB, Breast carcinoma tumor characteristics in black and white women Cancer 83:2509\u20132515, 1998","journal-title":"Cancer"},{"key":"9118_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F","volume":"92","author":"KC Chu","year":"2001","unstructured":"Chu KC, Anderson WF, Fritz A, Frequency distributions of breast cancer characteristics classified by estrogen and progesterone receptor status for eight racial\/ethnic groups Cancer92:37\u201345, 2001","journal-title":"Cancer"},{"key":"9118_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1020299707510","volume":"76","author":"WF Anderson","year":"2002","unstructured":"Anderson WF, Chatterjee N, Ershler WB, Brawley OW, Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database Breast Cancer Res Treat76:27\u201336, 2002","journal-title":"Breast Cancer Res Treat"},{"key":"9118_CR16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","volume":"288","author":"KM Flegal","year":"2002","unstructured":"Flegal KM, Carroll MD, Ogden CL, Johnson CL, Prevalence and trends in obesity among US adults, 1999\u20132000JAMA288:1723\u20131727, 2002","journal-title":"JAMA"},{"key":"9118_CR17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/oxfordjournals.aje.a009292","volume":"146","author":"BA Jones","year":"1997","unstructured":"Jones BA, Kasl SV, Curnen MG, Owens PH, Dubrow R, Severe obesity as an explanatory factor for the black\/white difference in stage at diagnosis of breast cancer Am J Epidemiol 146:394\u2013404, 1997","journal-title":"Am J Epidemiol"},{"key":"9118_CR18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/aje\/153.3.284","volume":"153","author":"PG Moorman","year":"2001","unstructured":"Moorman PG, Jones BA, Millikan RC, Hall IJ, Newman B, Race, anthropometric factors, and stage at diagnosis of breast cancer Am J Epidemiol 153:284\u2013291, 2001","journal-title":"Am J Epidemiol"},{"key":"9118_CR19","first-page":"107","volume":"3","author":"M Roach III","year":"1997","unstructured":"Roach M III, Cirrincione C, Budman D, Hayes D, Berry D, Younger J, Hart R, Henderson IC, Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541 Cancer J Sci Am3:107\u2013112, 1997","journal-title":"Cancer J Sci Am"},{"key":"9118_CR20","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/cncr.10830","volume":"95","author":"CK Cross","year":"2002","unstructured":"Cross CK, Harris J, Recht A, Race, socioeconomic status, and breast carcinoma in the U.S.: what have we learned from clinical studies? Cancer 95:1988\u20131999, 2002","journal-title":"Cancer"},{"key":"9118_CR21","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/cncr.11411","volume":"97","author":"KC Chu","year":"2003","unstructured":"Chu KC, Lamar CA, Freeman HP, Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment Cancer97:2853\u20132860, 2003","journal-title":"Cancer"},{"key":"9118_CR22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<80::AID-CNCR11>3.0.CO;2-B","volume":"80","author":"JJ Dignam","year":"1997","unstructured":"Dignam JJ, Redmond CK, Fisher B, Costantino J, Edwards BK, Prognosis among African-American women and white women with lymph node negative breast carcinoma: findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP) Cancer80:80\u201390, 1997","journal-title":"Cancer"},{"key":"9118_CR23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/oxfordjournals.jncimonographs.a003458","volume":"30","author":"JJ Dignam","year":"2001","unstructured":"Dignam JJ, Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women J Natl Cancer Inst Monogr30:36\u201343, 2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"9118_CR24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM198902233200801","volume":"320","author":"B Fisher","year":"1989","unstructured":"Fisher B, Redmond C, Dimitrov NV, Bowman D, Legault-Poisson S, Wickerham DL, Wolmark N, Fisher ER, Margolese R, Sutherland C, A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors N Engl J Med320:473\u2013478, 1989","journal-title":"N Engl J Med"},{"key":"9118_CR25","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1200\/JCO.1996.14.7.1982","volume":"14","author":"B Fisher","year":"1996","unstructured":"Fisher B, Dignam J, Mamounas EP, Costantino J, Wickerham DL, Redmond C, Wolmark N, Dimitrov NV, Bowman D, Glass AG, Atkins JN, Abramson N, Sutherland C, Aron B, Margolese RG, Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil J Clin Oncol14:1982\u20131992, 1996","journal-title":"J Clin Oncol"},{"key":"9118_CR26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1200\/JCO.2001.19.4.931","volume":"19","author":"B Fisher","year":"2001","unstructured":"Fisher B, Anderson S, Tan-Chiu E, Wolmark N, Wickerham DL, Fisher ER, Dimitrov NV, Atkins JN, Abramson N, Merajver S, Romond EH, Kardinal CG, Shibata HR, Margolese RG, Farrar WB, Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23 J Clin Oncol19:931\u2013942, 2001","journal-title":"J Clin Oncol"},{"key":"9118_CR27","unstructured":"United States Department of Health and Human Services. The Surgeon General\u2019s call to action to prevent and decrease overweight and obesity. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General, 2001. http:\/\/www.surgeongeneral.gov\/topics\/obesity\/calltoaction\/CalltoAction.pdf [Accessed October 11, 2005]"},{"key":"9118_CR28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0197-2456(84)90027-8","volume":"5","author":"RD Remington","year":"1984","unstructured":"Remington RD, Who should code cause of death in a clinical trial? Control Clin Trials 5:241\u2013244, 1984","journal-title":"Control Clin Trials"},{"key":"9118_CR29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/sim.4780110611","volume":"11","author":"EL Korn","year":"1992","unstructured":"Korn EL, Dorey FJ, Applications of crude incidence curves Stat Med11:813\u2013829, 1992","journal-title":"Stat Med"},{"key":"9118_CR30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2307\/2530374","volume":"34","author":"RL Prentice","year":"1978","unstructured":"Prentice RL, Kalbfleisch JD, Peterson AV, Flournoy N, Farewell VT, Breslow NE, The analysis of failure times in the presence of competing risks Biometrics 34:541\u2013554, 1978","journal-title":"Biometrics"},{"key":"9118_CR31","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/sj.bjc.6690279","volume":"79","author":"W Sauerbrei","year":"1999","unstructured":"Sauerbrei W, Royston P, Bojar H, Schmoor C, Schumacher M, Modeling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG) Br J Cancer79:1752\u20131760, 1999","journal-title":"Br J Cancer"},{"key":"9118_CR32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1467-789X.2003.00120.x","volume":"4","author":"PT Katzmarzyk","year":"2003","unstructured":"Katzmarzyk PT, Janssen I, Ardern CI, Physical inactivity, excess adiposity and premature mortality Obes Rev4:257\u2013290, 2003","journal-title":"Obes Rev"},{"key":"9118_CR33","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.1996.14.11.3000","volume":"14","author":"GL Rosner","year":"1996","unstructured":"Rosner GL, Hargis JB, Hollis DR, Budman DR, Weiss RB, Henderson IC, Schilsky RL, Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from Cancer and Leukemia Group B study 8541 J Clin Oncol14:3000\u20133008, 1996","journal-title":"J\u2423Clin Oncol"},{"key":"9118_CR34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1010635328299","volume":"66","author":"Y Madarnas","year":"2001","unstructured":"Madarnas Y, Sawka CA, Franssen E, Bjarnason GA, Are medical oncologists biased in their treatment of the large woman with breast cancer? Breast Cancer Res Treat66:123\u2013133, 2001","journal-title":"Breast Cancer Res Treat"},{"key":"9118_CR35","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1200\/JCO.2003.05.002","volume":"21","author":"GH Lyman","year":"2003","unstructured":"Lyman GH, Dale DC, Crawford J, Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices J Clin Oncol21:4524\u20134531, 2003","journal-title":"J Clin Oncol"},{"key":"9118_CR36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/annonc\/mdh241","volume":"15","author":"JJ Dignam","year":"2004","unstructured":"Dignam JJ, Mamounas EP, Obesity and breast cancer prognosis: an expanding body of evidence (editorial) Ann Oncol15:850\u2013851, 2004","journal-title":"Ann Oncol"},{"key":"9118_CR37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/oxfordjournals.aje.a114156","volume":"22","author":"WC Willett","year":"1985","unstructured":"Willett WC, Browne ML, Bain C, Lipnick RJ, Stampfer MJ, Rosner B, Colditz GA, Hennekens CH, Speizer FE, Relative weight and risk of breast cancer among premenopausal women Am J Epidemiol22:731\u2013740, 1985","journal-title":"Am J Epidemiol"},{"key":"9118_CR38","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/aje\/152.6.514","volume":"152","author":"PA Brandt van den","year":"2000","unstructured":"van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, Rohan T, Smith-Warner SA, Speizer FE, Willett WC, Wolk A, Hunter DJ, Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk Am J Epidemiol152:514\u2013527, 2000","journal-title":"Am J Epidemiol"},{"key":"9118_CR39","first-page":"5699","volume":"9","author":"Y Miyoshi","year":"2004","unstructured":"Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S, Association of serum adiponectin levels with breast cancer risk Clin Cancer Res9:5699\u20135704, 2004","journal-title":"Clin Cancer Res"},{"key":"9118_CR40","doi-asserted-by":"crossref","first-page":"10,715","DOI":"10.1073\/pnas.0403390101","volume":"101","author":"JA Menendez","year":"2004","unstructured":"Menendez JA, Vellon L, Mehmi I, Oza BP, Ropero S, Colomer R, Lupu R, Inhibition of fatty acid synthase (FAS) suppresses HER2\/neu (erbB-2) oncogene overexpression in cancer cells Proc Natl Acad Sci USA 101:10,715\u201310,720, 2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"9118_CR41","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jama.1997.03550170037029","volume":"278","author":"Z Huang","year":"1997","unstructured":"Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC, Dual effects of weight and weight gain on breast cancer risk JAMA 278:1407\u20131411, 1997","journal-title":"JAMA"},{"key":"9118_CR42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1025481505537","volume":"81","author":"JJ Griggs","year":"2003","unstructured":"Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW, Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy Breast Cancer Res Treat81:21\u201331, 2003","journal-title":"Breast Cancer Res Treat"},{"key":"9118_CR43","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1200\/JCO.2005.12.633","volume":"23","author":"H Hershman","year":"2005","unstructured":"Hershman H, McBride R, Jacobson JS, Lamerato L, Roberts K, Grann V, Neugut AI, Racial disparities in treatment and survival among women with early-stage breast cancer J Clin Oncol23:6639\u20136646, 2005","journal-title":"J Clin Oncol"},{"key":"9118_CR44","first-page":"S12","volume":"82","author":"KS Albain","year":"2003","unstructured":"Albain KS, Unger JM, Hutchins LF, Rivkin SE, Martino S, Livingston RB, Osborne CK, Outcomes of African Americans on Southwest Oncology Group (SWOG) breast cancer adjuvant therapy trials Breast Cancer Res Treat2003;82:S12","journal-title":"Breast Cancer Res Treat"},{"key":"9118_CR45","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/cncr.20500","volume":"101","author":"BA Jones","year":"2004","unstructured":"Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R, Curnen MM, Soler-Vila H, Beeghly A, Duan F, Owens P, African American\/white differences in breast carcinoma: p53 and other tumor characteristics Cancer 101:1293\u20131301, 2004","journal-title":"Cancer"},{"key":"9118_CR46","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1002\/cncr.20279","volume":"100","author":"PL Porter","year":"2004","unstructured":"Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, Coates RJ, Eley JW, Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma Cancer 100:2533\u20132542, 2004","journal-title":"Cancer"},{"key":"9118_CR47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cncr.10639","volume":"95","author":"LA Newman","year":"2002","unstructured":"Newman LA, Bunner S, Carolin K, Bouwman D, Kosir MA, White M, Schwartz A, Ethnicity related differences in the survival of young breast carcinoma patients Cancer 95:21\u201327, 2002","journal-title":"Cancer"},{"key":"9118_CR48","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1158\/1078-0432.CCR-03-0514","volume":"10","author":"J Mehrotra","year":"2004","unstructured":"Mehrotra J, Ganpat MM, Kanaan Y, Fackler MJ, McVeigh M, Lahti-Domenici J, Polyak K, Argani P, Naab T, Garrett E, Parmigiani G, Broome C, Sukumar S, Estrogen receptor\/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women Clin Cancer Res 10:2052\u20132057, 2004","journal-title":"Clin Cancer Res"},{"key":"9118_CR49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1200\/JCO.1999.17.1.120","volume":"17","author":"PJ Goodwin","year":"1999","unstructured":"Goodwin PJ, Ennis M, Pritchard KI, McCready D, Koo J, Sidlofsky S, Trudeau M, Hood N, Redwood S, Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis J Clin Oncol17:120\u2013129, 1999","journal-title":"J Clin Oncol"},{"key":"9118_CR50","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.2001.19.9.2381","volume":"19","author":"W Demark-Wahnefried","year":"2001","unstructured":"Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, Marcom PK, Blackwell K, Rimer BK, Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patient receiving adjuvant chemotherapy J Clin Oncol19:2381\u20132389, 2001","journal-title":"J Clin Oncol"},{"key":"9118_CR51","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1200\/JCO.2005.04.036","volume":"23","author":"ML Irwin","year":"2005","unstructured":"Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Gilliland FD, Ballard-Barbash R, Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors J Clin Oncol 23:774\u2013782, 2005","journal-title":"J Clin Oncol"},{"key":"9118_CR52","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1200\/JCO.2005.01.079","volume":"23","author":"CH Kroenke","year":"2005","unstructured":"Kroenke CH, Chen WY, Rosner B, Holmes MD, Weight, weight gain and survival after breast cancer J Clin Oncol 23:1370\u20131378, 2005","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-005-9118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-005-9118-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-005-9118-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:29:32Z","timestamp":1559233772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-005-9118-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,6]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["9118"],"URL":"https:\/\/doi.org\/10.1007\/s10549-005-9118-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,6]]}}}